Lv71
3845 积分 2022-01-07 加入
Predictors of treatment-emergent resistance to dolutegravir
13天前
已完结
甘草素联合阿霉素诱导人肝癌HepG2细胞及裸鼠肝癌移植瘤凋亡及其分子机制的研究
2个月前
已完结
2019年江苏省学校食物中毒暴发事件分析
2个月前
已完结
2016年江苏省食源性疾病暴发事件流行病学分析
2个月前
已完结
Safety and efficacy of switching to bictegravir–lenacapavir versus continuing bictegravir–emtricitabine–tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
3个月前
已完结
Safety and efficacy of switching to bictegravir–lenacapavir versus continuing bictegravir–emtricitabine–tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
3个月前
已关闭
Safety and efficacy of switching to bictegravir–lenacapavir versus continuing bictegravir–emtricitabine–tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
3个月前
已关闭
Safety and efficacy of switching to bictegravir–lenacapavir versus continuing bictegravir–emtricitabine–tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
3个月前
已关闭
The Implications of HIV-1 Subtypes on Pathogenesis, Reservoirs and Cure Strategies
5个月前
已完结
Simple and Effective Purification of Recombinant Peptide Drug, hPTH (1-34), Expressed in E. coli Host
5个月前
已完结
皖公网安备34019202002308
